Crystal structure of the ENT domain of human EMSY

被引:18
作者
Chavali, GB
Ekblad, CMS
Basu, BP
Brissett, NC
Veprintsev, D
Hughes-Davies, L
Kouzarides, T
Itzhaki, LS [1 ]
Doherty, AJ
机构
[1] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England
[2] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2XY, England
[3] MRC, Res Ctr, Canc Cell Unit Hutchison, Cambridge CB2 2XZ, England
[4] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England
[5] MRC, Res Ctr, Dept Oncol Hutchison, Cambridge CB2 2XZ, England
[6] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QR, England
[7] Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England
基金
英国生物技术与生命科学研究理事会;
关键词
EMSY; BRCA2; ENT domain; protein structure; crystallography;
D O I
10.1016/j.jmb.2005.05.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
EMSY is a recently discovered gene encoding a BRCA2-associated protein and is amplified in some sporadic breast and ovarian cancers. The EMSY sequence contains no known domain except for a conserved similar to 100 residue segment at the N terminus. This so-called ENT domain is unique in the human genome, although multiple copies are found in Arabidopsis proteins containing members of the Royal family of chromatin remodelling domains. Here, we report the crystal structure of the ENT domain of EMSY, consisting of a unique arrangement of five alpha-helices that fold into a helical bundle arrangement. The fold shares regions of structural homology with the DNA-binding domain of homeodomain proteins. The ENT domain forms a homodimer via the anti-parallel packing of the extended N-terminal alpha-helix of each molecule. It is stabilized mainly by hydrophobic residues at the dimer interface and has a dissociation constant in the low micromolar range. The dimerisation of EMSY mediated by the ENT domain could provide flexibility for it to bind two or more different substrates simultaneously. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:964 / 973
页数:10
相关论文
共 26 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Free R value: Cross-validation in crystallography [J].
Brunger, AT .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :366-396
[3]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[4]   COVARIATION OF RESIDUES IN THE HOMEODOMAIN SEQUENCE FAMILY [J].
CLARKE, ND .
PROTEIN SCIENCE, 1995, 4 (11) :2269-2278
[5]  
EKBLAD CMS, 2005, IN PRESS EMBO REP
[6]   ACCURATE BOND AND ANGLE PARAMETERS FOR X-RAY PROTEIN-STRUCTURE REFINEMENT [J].
ENGH, RA ;
HUBER, R .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :392-400
[7]   Further additions to MolScript version 1.4, including reading and contouring of electron-density maps [J].
Esnouf, RM .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :938-940
[8]   POVScript+:: a program for model and data visualization using persistence of vision ray-tracing [J].
Fenn, TD ;
Ringe, D ;
Petsko, GA .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2003, 36 (02) :944-947
[9]   ESPript:: analysis of multiple sequence alignments in PostScript [J].
Gouet, P ;
Courcelle, E ;
Stuart, DI ;
Métoz, F .
BIOINFORMATICS, 1999, 15 (04) :305-308
[10]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723